MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)

NCT00446186 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

945

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis Allergic

Interventions

DRUG: MK0476, montelukast sodium / Duration of Treatment: 2 Weeks
DRUG: Comparator: placebo / Duration of Treatment: 2 Weeks

Sponsor

Organon and Co